Yasufumi Katanasaka Selected Research

GATA4 Transcription Factor

1/2022	Multimerization of the GATA4 transcription factor regulates transcriptional activity and cardiomyocyte hypertrophic response.
12/2016	Regulation of Cardiac Transcription Factor GATA4 by Post-Translational Modification in Cardiomyocyte Hypertrophy and Heart Failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasufumi Katanasaka Research Topics

Disease

24	Heart Failure 06/2022 - 01/2011
16	Hypertrophy 06/2022 - 01/2013
13	Cardiomegaly (Heart Hypertrophy) 01/2022 - 01/2016
12	Neoplasms (Cancer) 10/2019 - 01/2004
10	Fibrosis (Cirrhosis) 01/2022 - 01/2011
7	Myocardial Infarction 01/2022 - 01/2011
5	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 12/2014
4	Inflammation (Inflammations) 10/2019 - 12/2014
3	Coronary Artery Disease (Coronary Atherosclerosis) 04/2022 - 12/2016
2	Atherosclerosis 04/2022 - 01/2016
2	Left Ventricular Dysfunction 11/2021 - 01/2015
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 07/2021 - 02/2021
2	Obesity 01/2020 - 12/2014
2	Heart Diseases (Heart Disease) 01/2018 - 01/2016
2	Carcinoma (Carcinomatosis) 12/2010 - 01/2010
1	Cardiotoxicity 01/2022
1	Periodontal Diseases (Periodontal Disease) 11/2021
1	Hypertension (High Blood Pressure) 07/2021
1	Systolic Heart Failure 02/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Insulin Resistance 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Chronic Renal Insufficiency 11/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Glucose Intolerance 01/2019
1	Ischemia 01/2018
1	Hypercholesterolemia 12/2016
1	Reperfusion Injury 02/2016
1	Retinoblastoma (Glioblastoma, Retinal) 01/2016

Drug/Important Bio-Agent (IBA)

13	CurcuminIBA 06/2022 - 01/2011
7	Histone Acetyltransferases (Histone Acetyltransferase)IBA 06/2022 - 01/2011
7	Proteins (Proteins, Gene)FDA Link 04/2022 - 12/2007
6	Liposomes (Liposome)IBA 01/2013 - 01/2004
5	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 06/2022 - 01/2016
5	Pharmaceutical PreparationsIBA 01/2022 - 01/2013
5	Peptides (Polypeptides)IBA 01/2013 - 01/2004
4	Histones (Histone)IBA 01/2022 - 01/2020
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 12/2010
4	Transcription Factors (Transcription Factor)IBA 12/2016 - 01/2013
3	AdipokinesIBA 04/2022 - 12/2014
3	Biological ProductsIBA 02/2021 - 04/2018
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2015
2	AngiopoietinsIBA 04/2022 - 04/2013
2	Messenger RNA (mRNA)IBA 01/2022 - 11/2021
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022 - 02/2021
2	GATA4 Transcription FactorIBA 01/2022 - 12/2016
2	TeaIBA 11/2021 - 01/2020
2	zerumboneIBA 11/2021 - 02/2021
2	Rosuvastatin Calcium (Crestor)FDA Link 01/2021 - 12/2016
2	pitavastatin (itavastatin)FDA Link 01/2021 - 12/2016
2	PolyphenolsIBA 11/2020 - 01/2018
2	1,5- bis(3,5- bis(methoxymethoxy)phenyl)penta- 1,4- dien- 3- oneIBA 01/2020 - 12/2017
2	oxidized low density lipoproteinIBA 01/2019 - 01/2016
2	WD repeat containing planar cell polarity effectorIBA 02/2016 - 12/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2014 - 12/2010
2	ErbB Receptors (EGF Receptor)IBA 06/2014 - 04/2013
2	SolventsIBA 01/2014 - 01/2011
2	Everolimus FDA Link 09/2012 - 12/2011
2	dpp-cndacIBA 05/2008 - 01/2004
1	pyrazoleIBA 06/2022
1	AnthracyclinesIBA 01/2022
1	Docosahexaenoic AcidsIBA 01/2022
1	Eicosapentaenoic AcidIBA 01/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2021
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 12/2021
1	sarpogrelateIBA 12/2021
1	CollagenIBA 11/2021
1	Atrial Natriuretic Factor (ANF)IBA 11/2021
1	Metformin (Glucophage)FDA LinkGeneric 10/2021
1	SaltsIBA 07/2021
1	ginger extractIBA 02/2021
1	mangostinIBA 01/2021
1	Coenzyme A (CoA)IBA 01/2021
1	Mitogen-Activated Protein Kinase 3IBA 11/2020
1	Carrier Proteins (Binding Protein)IBA 11/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	AcetyltransferasesIBA 01/2020
1	LipidsIBA 01/2020
1	Catechin (Z 7300)IBA 01/2020
1	Cystatin CIBA 11/2019
1	Phenylalanine (L-Phenylalanine)FDA Link 10/2019
1	Valine (L-Valine)FDA Link 10/2019
1	Janus Kinase 2IBA 10/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	DiarylheptanoidsIBA 04/2018
1	Phenol (Carbolic Acid)FDA Link 04/2018
1	InflammasomesIBA 01/2018
1	Angiotensin IIIBA 01/2018
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2018
1	DNA (Cytosine-5-)-Methyltransferases (DNA (Cytosine 5) Methyltransferase)IBA 01/2018
1	nobiletinIBA 12/2017
1	Lipoproteins (Lipoprotein)IBA 01/2016
1	Positive Transcriptional Elongation Factor BIBA 01/2016
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2016
1	Co-Repressor ProteinsIBA 01/2016
1	Tyrosine (L-Tyrosine)FDA Link 01/2016
1	CyclinsIBA 01/2016

Therapy/Procedure

12	Therapeutics 02/2021 - 01/2004
3	Drug Therapy (Chemotherapy) 01/2021 - 05/2008
2	Ligation 10/2019 - 01/2018